NIH funded study finds infection-related hospitalizations linked to increased risk of heart failure: Bethesda, Maryland Thursday, February 13, 2025, 18:00 Hrs [IST] A study funded ...

GenSight Biologics announces efficacy and safety results for Lumevoq gene therapy at the conclusion of the REFLECT phase III clinical study: Paris Thursday, February 13, 2025, 17: ...

Utthunga and VindAir to advance smart solutions for pharma and healthcare industries: Our Bureau, Bengaluru Thursday, February 13, 2025, 16:45 Hrs [IST] Utthunga, a leading provid ...

Shelton, Connecticut Thursday, February 13, 2025, 16:00 Hrs [IST] ...

National Institutes of Health (NIH) scientists and their colleagues report that a single dose of a broadly neutralizing antibody (bnAb) administered prior to virus exposure protects macaques from ...

Lineage Cell Therapeutics initiates DOSED clinical study of OPC1 for spinal cord injury: Carlsbad, California Thursday, February 13, 2025, 14:00 Hrs [IST] Lineage Cell Therapeutic ...

Alloy Therapeutics enters multi-year collaboration with Pfizer to develop new antibody discovery platform: Boston, Massachusetts Thursday, February 13, 2025, 13:00 Hrs [IST] Alloy ...

Palo Alto, California Thursday, February 13, 2025, 12:00 Hrs [IST] ...

NIH-funded clinical trial will evaluate new dengue therapeutic: Bethesda, Maryland Thursday, February 13, 2025, 11:00 Hrs [IST] A clinical trial supported by the National Institut ...

MaxCyte inks strategic platform license agreement with TG Therapeutics to advance its autoimmune cell therapeutics programmes: Rockville, Maryland Thursday, February 13, 2025, 10: ...

BostonGene collaborates with BeiGene to advance biomarker discovery in mantle cell lymphoma: Waltham, Massachusetts Thursday, February 13, 2025, 09:00 Hrs [IST] BostonGene, a lead ...

Nandita Vijayasimha, Bengaluru Thursday, February 13, 2025, 08:00 Hrs [IST] ...